List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amyotrophic Lateral Sclerosis (ALS) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amyotrophic Lateral Sclerosis (ALS) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit) of Key Manufacturers (2019-2024)
Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amyotrophic Lateral Sclerosis (ALS) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amyotrophic Lateral Sclerosis (ALS), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amyotrophic Lateral Sclerosis (ALS), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amyotrophic Lateral Sclerosis (ALS), Product Type & Application
Table 12. Global Key Manufacturers of Amyotrophic Lateral Sclerosis (ALS), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amyotrophic Lateral Sclerosis (ALS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2019-2024) & (K Unit)
Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2019-2024)
Table 19. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2025-2030) & (K Unit)
Table 20. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2025-2030)
Table 21. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2019-2024)
Table 23. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2025-2030)
Table 25. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)
Table 27. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2025-2030) & (K Unit)
Table 28. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)
Table 32. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2025-2030) & (K Unit)
Table 33. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2019-2024) & (K Unit)
Table 37. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2025-2030) & (K Unit)
Table 38. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)
Table 42. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2025-2030) & (K Unit)
Table 43. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2019-2024) & (K Unit)
Table 47. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2025-2030) & (K Unit)
Table 48. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit) by Type (2019-2024)
Table 51. Global Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit) by Type (2025-2030)
Table 52. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2019-2024)
Table 53. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2025-2030)
Table 54. Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2019-2024)
Table 57. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2025-2030)
Table 58. Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit) by Application (2019-2024)
Table 61. Global Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit) by Application (2025-2030)
Table 62. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2019-2024)
Table 63. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2025-2030)
Table 64. Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2019-2024)
Table 67. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2025-2030)
Table 68. Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/Unit) by Application (2025-2030)
Table 70. Mitsubishi Tanabe Pharma Corporation Information
Table 71. Mitsubishi Tanabe Pharma Description and Business Overview
Table 72. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product
Table 74. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Mylan Pharma Corporation Information
Table 81. Mylan Pharma Description and Business Overview
Table 82. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product
Table 84. Mylan Pharma Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Amyotrophic Lateral Sclerosis (ALS) Product
Table 89. Apotex Recent Developments/Updates
Table 90. Glemark Generics Corporation Information
Table 91. Glemark Generics Description and Business Overview
Table 92. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product
Table 94. Glemark Generics Recent Developments/Updates
Table 95. Covis Pharma Corporation Information
Table 96. Covis Pharma Description and Business Overview
Table 97. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product
Table 99. Covis Pharma Recent Developments/Updates
Table 100. Sun Pharma Corporation Information
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product
Table 104. Sun Pharma Recent Developments/Updates
Table 105. Lunan Pharma Corporation Information
Table 106. Lunan Pharma Description and Business Overview
Table 107. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product
Table 109. Lunan Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Amyotrophic Lateral Sclerosis (ALS) Distributors List
Table 113. Amyotrophic Lateral Sclerosis (ALS) Customers List
Table 114. Amyotrophic Lateral Sclerosis (ALS) Market Trends
Table 115. Amyotrophic Lateral Sclerosis (ALS) Market Drivers
Table 116. Amyotrophic Lateral Sclerosis (ALS) Market Challenges
Table 117. Amyotrophic Lateral Sclerosis (ALS) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amyotrophic Lateral Sclerosis (ALS)
Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2023 & 2030
Figure 4. Riluzole Product Picture
Figure 5. Edaravone (Radicava) Product Picture
Figure 6. Other Product Picture
Figure 7. Global Amyotrophic Lateral Sclerosis (ALS) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Drugs Store
Figure 11. Other
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Sales (2019-2030) & (K Unit)
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Average Price (USD/Unit) & (2019-2030)
Figure 16. Amyotrophic Lateral Sclerosis (ALS) Report Years Considered
Figure 17. Amyotrophic Lateral Sclerosis (ALS) Sales Share by Manufacturers in 2023
Figure 18. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Amyotrophic Lateral Sclerosis (ALS) Players: Market Share by Revenue in 2023
Figure 20. Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2030)
Figure 23. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2030)
Figure 27. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2019-2030)
Figure 35. China Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2030)
Figure 46. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Amyotrophic Lateral Sclerosis (ALS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Amyotrophic Lateral Sclerosis (ALS) by Type (2019-2030)
Figure 56. Global Revenue Market Share of Amyotrophic Lateral Sclerosis (ALS) by Type (2019-2030)
Figure 57. Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Amyotrophic Lateral Sclerosis (ALS) by Application (2019-2030)
Figure 59. Global Revenue Market Share of Amyotrophic Lateral Sclerosis (ALS) by Application (2019-2030)
Figure 60. Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/Unit) by Application (2019-2030)
Figure 61. Amyotrophic Lateral Sclerosis (ALS) Value Chain
Figure 62. Amyotrophic Lateral Sclerosis (ALS) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed